Skip to main content
The Lancet Regional Health - Europe logoLink to The Lancet Regional Health - Europe
. 2022 Jul 22;19:100449. doi: 10.1016/j.lanepe.2022.100449

Correction to “Concerns about the external validity of the study ‘prevalence of persistent symptoms after treatment for Lyme borreliosis: A prospective observational cohort study’-authors’ reply”

PMCID: PMC9309420  PMID: 35898654

The authors have noticed an error in the fourth sentence of the Correspondence where it should read “This was an improvement of 3–8% on the fatigue severity scale range.” instead of “This was a substantial improvement of 6–8% on the fatigue severity scale range.”


Articles from The Lancet Regional Health - Europe are provided here courtesy of Elsevier

RESOURCES